Skip to main content

Jones James's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Aug 19, 2022

Accession no.
0001209191-22-046898
Filed
Aug 19, 2022
Trade date
Jul 1-Aug 15, 2022
Filing delay
49 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 28 non-derivative transactions. Open-market purchases total $2.45K. It was filed 49 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jones JamesCIK 0001490829Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 1, 2022Common StockPPurchaseAcquired+30$2.11+$63.322,228Direct
Jul 5, 2022Common StockPPurchaseAcquired+43$2.18+$93.7422,271Direct
Jul 6, 2022Common StockPPurchaseAcquired+43$2.11+$90.7322,314Direct
Jul 7, 2022Common StockPPurchaseAcquired+43$2.18+$93.7422,357Direct
Jul 8, 2022Common StockPPurchaseAcquired+43$2.21+$95.0322,400Direct
Jul 12, 2022Common StockPPurchaseAcquired+43$2.25+$96.7522,443Direct
Jul 14, 2022Common StockPPurchaseAcquired+43$2.28+$98.0422,486Direct
Jul 15, 2022Common StockPPurchaseAcquired+43$2.23+$95.8922,529Direct
Jul 18, 2022Common StockPPurchaseAcquired+37$2.41+$89.1722,566Direct
Jul 19, 2022Common StockPPurchaseAcquired+37$2.47+$91.3922,603Direct
Jul 20, 2022Common StockPPurchaseAcquired+37$2.52+$93.2422,640Direct
Jul 21, 2022Common StockPPurchaseAcquired+37$2.54+$93.9822,677Direct
Jul 22, 2022Common StockPPurchaseAcquired+37$2.53+$93.6122,714Direct
Jul 25, 2022Common StockPPurchaseAcquired+37$2.48+$91.7622,751Direct
Jul 26, 2022Common StockPPurchaseAcquired+37$2.47+$91.3922,788Direct
Jul 27, 2022Common StockPPurchaseAcquired+30$2.36+$70.822,818Direct
Jul 28, 2022Common StockPPurchaseAcquired+37$2.28+$84.3622,855Direct
Jul 29, 2022Common StockPPurchaseAcquired+37$2.28+$84.3622,892Direct
Aug 1, 2022Common StockPPurchaseAcquired+37$2.34+$86.5822,929Direct
Aug 3, 2022Common StockPPurchaseAcquired+20$2.45+$4922,949Direct
Aug 4, 2022Common StockPPurchaseAcquired+37$2.17+$80.2922,986Direct
Aug 5, 2022Common StockPPurchaseAcquired+37$2.12+$78.4423,023Direct
Aug 8, 2022Common StockPPurchaseAcquired+40$2.19+$87.623,063Direct
Aug 9, 2022Common StockPPurchaseAcquired+40$2.19+$87.623,103Direct
Aug 10, 2022Common StockPPurchaseAcquired+40$2.19+$87.623,143Direct
Aug 11, 2022Common StockPPurchaseAcquired+40$2.46+$98.423,183Direct
Aug 12, 2022Common StockPPurchaseAcquired+40$2.52+$100.823,223Direct
Aug 15, 2022Common StockPPurchaseAcquired+32$2.45+$78.423,255Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)